Shares in DocMorris experienced a decline on Thursday as the Swiss online pharmacy reported lower revenue for the third quarter. The decrease was attributed to a drop in demand for paper-prescription business. Consequently, the company has revised its guidance for the year.
At 1149 GMT, the stock witnessed a 14% decline, reaching CHF40.56. Earlier in the day, it had fallen by as much as 16%.
DocMorris stated that its external revenue for the third quarter decreased by 4.5% in local currency, amounting to 256 million Swiss francs ($284.8 million).
Although the company anticipates revenue growth in the final quarter, it has adjusted its projection for a 2023 adjusted loss before interest, taxes, depreciation, and amortization. The new range is between CHF30 million and CHF40 million, compared to the previous forecasted loss of CHF20 million to CHF40 million.
Moreover, the group now expects a high single-digit percentage decline in external revenue in local currency for this year. This is worse than the previously anticipated mid-single-digit percentage contraction.
TSM Reports 25% Fall in Q3 Net Profit
Related Articles
![Canadian PM Justin Trudeau and Wife Announce Separation](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Canadian PM Justin Trudeau and Wife Announce Separation
Canadian Prime Minister Justin Trudeau and his wife, Sophie Gregoire Trudeau, have announced their separation after 18 years of marriage. This decision was made...
![Navigating the Shadows of the Markets](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Navigating the Shadows of the Markets
Explore the enigma of the financial markets, decode Powell's speech, and understand the allure of quick gains. Find out how to navigate uncertain times and adop...
![Fresenius Upgrades Earnings Targets for 2021](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Fresenius Upgrades Earnings Targets for 2021
Fresenius, a German health-care company, raises its earnings targets for 2021 following a strong performance in the first three quarters.